Marshall Goldsmith

FEBRUARY 8, 2018

Deepa Prahalad – Focused on design and emerging markets. 14th Administrator, United States Agency for International Development. a holding company that operates seven distinct business. Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Marketing activities today generate unprecedented amounts of data.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

AUGUST 3, 2016

Regulators try to model how prices, sales, and even the combining parties’ research and development efforts will change after a merger. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity 115

Diversity Innovation Biotechnology Short-term 115

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. It’s not that development itself isn’t important. So they’re looking for ways to cultivate those competencies and, in the process, feeding the fad-driven leadership development market. Paul Garbett for HBR.

Leadership Pipeline 12

Leadership Pipeline Leadership After Action Review Pharmaceuticals 12

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). imposing technological platforms developed for the U.S.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. In the last half decade, however, several new HCV treatments have been developed with cure rates exceeding 90%.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. adults were at risk of developing type 2 diabetes in 2015. The same is true for social innovators.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. That can be a powerful marketing technique if you have the market muscle to pull it off. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 26, 2017

The innovation of the Bolognese silk makers was to operate the Lucca machine with a hydraulic wheel, instead of by hand. Bolognese yarns were sold to the doges of Venice or exchanged for spices and salt, and they were also exported to the large international markets, to France, Germany, England and even to the East.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. ” CEOs also worried about whether their high potential employees were being properly developed. Operating in a Global Marketplace. One area that proved especially challenging was mobility.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

JANUARY 5, 2018

But over and over again in our three decades of experience as talent development and retention specialists, we’ve seen that companies consistently overlook half of them. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. The petition was seen as instrumental in getting the city council to adopt new regulations which permitted Uber to operate legally. In the U.S., In the U.S.,

Licensing 9

Licensing Proposal Retail Long-term 9

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Each of the potential business benefits of 3D printing carries tax implications that could alter the equation for any anticipated operating efficiency or return on investment. Are there operations you would shed?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

MARCH 27, 2018

Facebook, at that time, allowed app developers to collect this personal data. ” By that I mean companies that control a key platform which, like a coral reef, attracts to its ecosystem users, sellers, advertisers, software developers, apps, and accessory makers. But this was not the first time its policies were violated. .”

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets. Facilitate discussion between competitors.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. That can be a powerful marketing technique if you have the market muscle to pull it off. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Often when superstar cities fall, they tend to be advanced economy cities, replaced by a developing economy city.

Industry 12

Industry Company GDP Bottom-up 12